| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP1049679B1 Sulphonamide derivatives for treatment of cns disorders |
| 06/01/2005 | EP1009758B1 Meta-benzamidine derivatives as serine protease inhibitors |
| 06/01/2005 | EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 06/01/2005 | CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 06/01/2005 | CN1204121C 1, 4-substituted cyclic amine derivatives or dihydro indole derivatives and medicines containing same |
| 05/31/2005 | US6900328 Stabilizer for polymers; photostability, oxidation resistance |
| 05/31/2005 | US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 05/26/2005 | WO2005047264A1 Process for producing dihydroisoquinoline zwitterions |
| 05/26/2005 | WO2005047263A1 Method for producing cyclic, n-substituted alpha-iminocarboxylic acids |
| 05/26/2005 | WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | WO2005046578A2 Isoquinolinone potassium channel inhibitors |
| 05/26/2005 | WO2005030791A3 Isoquinolinone potassium channel inhibitors |
| 05/26/2005 | US20050113576 especially isoquinolines 5-substituted with urea, carboxamide or carbamate groups, e.g., N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; useful for treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113407 for example, (Naphthalen-2-yl)-[6,7-dimethoxy-4-(1H-tetrazol-5-yl)-isoquinolin-1-yl]-methanone, (Naphthalen-1-yl)-[6,7-dimethoxy-4-(1H-tetrazol-5-yl)-isoquinolin-1-yl]-methanone |
| 05/26/2005 | US20050113399 Platelet ADP receptor inhibitors; ADP (adenosine 5'-diphosphate); thrombosis; contain thien-2-yl-sulfonylurea groups; 1-(thiophen-2-ylsulfonyl)-3-(4-(7-fluoro-6-(sec or tert-amino)-1-oxo-(3,4-dihydro)isoquinolin-2(1H)-yl)aryl)urea |
| 05/26/2005 | US20050113246 Cleaning compound containing organonitrogen compounds |
| 05/26/2005 | CA2544547A1 Process for producing dihydroisoquinoline zwitterions |
| 05/26/2005 | CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | CA2534342A1 Amino acid prodrugs |
| 05/25/2005 | EP1533294A1 Beta-alanine derivative and use thereof |
| 05/25/2005 | EP1532124A1 Novel compounds |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | DE10347383A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors |
| 05/25/2005 | CN1203061C Substituted isoquinolines, its preparing process, medical composition and its use for preparing medicine |
| 05/24/2005 | US6897224 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 05/24/2005 | US6897219 Central nervous system diosrders; analgesics; antiinflammatory agents |
| 05/19/2005 | WO2005044817A1 Modulators of cellular adhesion |
| 05/19/2005 | WO2005014576A8 Isoquinolinone derivative, process for producing the same and use thereof |
| 05/19/2005 | WO2004069162A3 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/19/2005 | US20050107409 drugs such as 3-{[7-(2,5-dihydropyrrol-1-yl-carbonyl)-quinazolin-4-yl]aminomethyl}-4-hydroxy-benzamidine, used as anticoagulants |
| 05/19/2005 | US20050107398 benzamide compounds labeled with detectable radionuclides that selectively bind to cancer cells, used for medical diagnosis such as tomography |
| 05/19/2005 | US20050107388 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050106109 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes |
| 05/19/2005 | DE10347386A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors |
| 05/19/2005 | CA2544678A1 Modulators of cellular adhesion |
| 05/18/2005 | EP1530472A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors |
| 05/18/2005 | CN1617856A Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 05/18/2005 | CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/18/2005 | CN1617725A Tyrosyl derivatives and their use as P2X7 receptor modulators |
| 05/17/2005 | US6894167 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | CA2306782C Isoquinolines as urokinase inhibitors |
| 05/12/2005 | WO2005043124A2 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors |
| 05/12/2005 | US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate |
| 05/12/2005 | US20050101644 Benzylether amine compounds useful as CCR-5 antagonists |
| 05/12/2005 | US20050101590 Cannabinoid receptor agonists |
| 05/12/2005 | US20050101584 Selective estrogen receptor-beta ligands |
| 05/12/2005 | US20050100511 Photoactive layer containing a lanthanide complex selected from [Ln( beta -enolate)3(phosphine oxide-pyridine N-oxide) derivatives |
| 05/11/2005 | EP0971898B1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 05/11/2005 | CN1613851A Extracting method for natural alkali of isoquinoline |
| 05/11/2005 | CN1613850A Use of natural alkali of isoquinoline |
| 05/10/2005 | US6890931 Methods of treating disorders with group I mGluR antagonists |
| 05/06/2005 | WO2005040355A2 Tao kinase modulators and methods of use |
| 05/06/2005 | WO2005040150A2 Glutamine fructose-6-phosphate amidotransferase (gfat) inhibitors |
| 05/06/2005 | WO2005040100A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2542494A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | CA2542064A1 Tao kinase modulators and methods of use |
| 05/06/2005 | CA2541690A1 Glutamine fructose-6-phosphate amidotransferase (gfat) inhibitors |
| 05/05/2005 | US20050096478 Derivatives of fluoro(hydro)carbons attached to an -alkylene-oxy-carbonyl-leaving group; reactive with amine-containing compounds to form a fluoro-substituted carbamyl protective group useful for the efficient separation, recovery and purification of synthsized organic compounds; libraries |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096347 Beta3-Adrenoreceptor agonists, agonist compositions and methods of using |
| 05/05/2005 | US20050096253 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/05/2005 | US20050095204 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes |
| 05/05/2005 | US20050095203 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes |
| 05/05/2005 | US20050095202 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes |
| 05/04/2005 | EP1528062A2 Process for the preparation of s-type 4-substituted hydroxypyranoindolidine compounds |
| 05/04/2005 | EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method |
| 05/03/2005 | US6888033 Contacting picornavirus with 2,6-dihydroxy acetophenone or its salt to inhibit replication of picornavirus |
| 04/28/2005 | WO2005037208A2 Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders |
| 04/28/2005 | WO2004108682A3 Tetrahydroisoquinolines as antagonists of the 5ht1b receptor |
| 04/28/2005 | WO2004092125A3 Using alkylmetal reagents for directed metalation of azaaromatics |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | US20050090525 carboxymethylated N-(nitrogen group functionalized alkyl- carbonylhydrazido)- or carbonylaminomethylcarbonyl)- substituted; integrin inhibitors used for combating thromboses, cardiac infarction, coronary heart diseases, arteriosclerosis, inflammation, tumors, osteoporosis, infections and restenosis |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050090485 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders |
| 04/27/2005 | EP1526130A1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 04/27/2005 | EP1011651B1 Method of treating diabetes and related disease states |
| 04/27/2005 | EP0741569B1 Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria |
| 04/27/2005 | CN1198614C Method for treating inflammatory diseases using pADPRT inhibitors |
| 04/26/2005 | US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent |
| 04/26/2005 | US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders |
| 04/26/2005 | US6884477 Electroluminescence device using liquid crystal compound |
| 04/21/2005 | WO2005035520A1 Substituted isoquinolinones |
| 04/21/2005 | WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035497A1 Caspase inhibitor comprising 2-alkyl-4-oxobutanoyl group and pharmaceutical composition thereof |
| 04/21/2005 | WO2005035471A1 Ether derivative |
| 04/21/2005 | WO2005034939A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
| 04/21/2005 | WO2005020882A3 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 04/21/2005 | WO2005011697A3 Sulfonamide derivatives with activity on protein kinase a and b |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | US20050085461 Benzenesulfonamide derivatives |
| 04/21/2005 | CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | CA2539882A1 Substituted isoquinolinones |